Synopsys (SNPS) Given Daily Coverage Optimism Score of 0.11

Media headlines about Synopsys (NASDAQ:SNPS) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Synopsys earned a coverage optimism score of 0.11 on Accern’s scale. Accern also assigned news headlines about the semiconductor company an impact score of 45.596661480842 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

Synopsys (NASDAQ:SNPS) traded up $0.66 during midday trading on Monday, hitting $90.37. 616,100 shares of the company’s stock were exchanged, compared to its average volume of 845,956. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.04. Synopsys has a fifty-two week low of $60.41 and a fifty-two week high of $94.80. The stock has a market capitalization of $13,439.26, a PE ratio of 106.32, a P/E/G ratio of 4.03 and a beta of 1.01.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, November 29th. The semiconductor company reported $0.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.12. Synopsys had a net margin of 5.01% and a return on equity of 5.78%. The firm had revenue of $696.60 million during the quarter, compared to analysts’ expectations of $650.72 million. During the same quarter last year, the company posted $0.77 earnings per share. The firm’s revenue was up 9.9% compared to the same quarter last year. sell-side analysts forecast that Synopsys will post 2.24 earnings per share for the current year.

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. downgraded shares of Synopsys from a “neutral” rating to an “underweight” rating and set a $87.00 price objective on the stock. in a research note on Tuesday, December 12th. Zacks Investment Research raised shares of Synopsys from a “hold” rating to a “buy” rating and set a $91.00 target price for the company in a research report on Tuesday, October 3rd. KeyCorp reissued an “overweight” rating and set a $106.00 target price (up previously from $86.00) on shares of Synopsys in a research report on Thursday, November 30th. Needham & Company LLC increased their target price on shares of Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, December 1st. Finally, TheStreet cut shares of Synopsys from an “a” rating to a “c+” rating in a research report on Wednesday, November 29th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $96.89.

In related news, Director Chrysostomos L. Nikias sold 21,073 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $85.88, for a total transaction of $1,809,749.24. Following the sale, the director now owns 32,466 shares in the company, valued at $2,788,180.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Chi-Foon Chan sold 3,750 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $89.78, for a total transaction of $336,675.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,897 shares of company stock valued at $5,370,098. 1.82% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Synopsys (SNPS) Given Daily Coverage Optimism Score of 0.11” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at

About Synopsys

Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with's FREE daily email newsletter.

Leave a Reply